Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates

Go back to Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates

Enzo Biochem (ENZ) Reports Q2 EPS of $0.09, CEO to Step Down

March 15, 2021 4:47 PM EDT

Enzo Biochem (NYSE: ENZ) reported Q2 EPS of $0.09, versus ($0.12) reported last year. Revenue for the quarter came in at $31.5 million, versus $19.4 million reported last year.

Dr. Elazar Rabbani, Founder and CEO, to step down as CEO and transition to a scientific... More